A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China

Chinese Medical Journal

Volumn 116, Issue 1, 2003, Pages 44-48

  Li, Longyun ^a   Cai, Boqiang ^a   Wang, Mengzhao ^a   Zhu, Yuanjue ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Antiviral agents; Influenza; Oseltamivir phosphate

Indexed keywords

OSELTAMIVIR; PLACEBO;

ADULT; AGED; ANAMNESIS; AREA UNDER THE CURVE; ARTICLE; CHILL; CHINA; CLINICAL TRIAL; COMMON COLD; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFLUENZA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NEUROLOGIC DISEASE; NOSE CONGESTION; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; SORE THROAT; SWEAT; SYMPTOMATOLOGY;

ACETAMIDES; ADULT; AGED; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEURAMINIDASE; OSELTAMIVIR;

EID: 0037257022     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Monto AS, Fleming DM, Henry, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis 1999;180:254-261.
2. Kim CU, Lew W, Williams MA, et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site. J Am Chem Soc 1997;119:681-690.
3. Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999;282:1240-1246.
4. Haden FG, Atmar RL, Schiilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-1343.
5. Treanor JJ, Haden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283:1016-1024.
6. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000;355:1845-1850.
7. McNicholl IR, McNicholl JJ. Neuraminidase inhibitor: zanamivir and oseltamivir. Ann Pharmacother 2001;35:57-70.